Literature DB >> 10900040

Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex.

Douwe F Westra1, Georges M G M Verjans2, Albert D M E Osterhaus2, Adriaan van Kooij1, Gjalt W Welling1, Albert Jan Scheffer1, T Hauw The1, Sytske Welling-Wester1.   

Abstract

The glycoproteins of herpes simplex virus type 1 (HSV-1) are important targets for the immune system in the control of HSV-1 infections. The humoral and T cell responses to the glycoprotein (g)H(t(His)):gL complex of HSV-1 were studied in seven HSV-1-seropositive and three HSV-1-seronegative healthy adults. In addition, responses to HSV-1 gD(t) were determined. As antigens, purified soluble recombinant forms of the gH(t(His)):gL complex produced by insect cells and of gD(t) produced by yeast cells were used. In contrast to seronegative donors, sera of all seropositive donors contained gH(t(His)): gL-specific IgG. Using peripheral blood (PB) T cells, gH(t(His)):gL-specific proliferative T cell responses were detected in all seropositive donors. Culture supernatants of PB T cells stimulated with recombinant gH(t(His)):gL contained high levels of interferon-gamma and no detectable interleukin-4, indicating their Th1 phenotype. These results show that naturally acquired HSV-1 infection induces gH:gL-specific humoral and T cell responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900040     DOI: 10.1099/0022-1317-81-8-2011

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins.

Authors:  D M Koelle; M Schomogyi; C McClurkan; S N Reymond; H B Chen
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells.

Authors:  Christopher R Cotter; Marie L Nguyen; Jacob S Yount; Carolina B López; John A Blaho; Thomas M Moran
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

3.  Use of baculovirus-expressed glycoprotein H in an enzyme-linked immunosorbent assay developed to assess exposure to chelonid fibropapillomatosis-associated herpesvirus and its relationship to the prevalence of fibropapillomatosis in sea turtles.

Authors:  Lawrence H Herbst; Shefali Lemaire; Ada R Ene; David J Heslin; Llewellyn M Ehrhart; Dean A Bagley; Paul A Klein; Jack Lenz
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

4.  Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.

Authors:  Susan E Vleck; Stefan L Oliver; Mike Reichelt; Jaya Rajamani; Leigh Zerboni; Carol Jones; James Zehnder; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

5.  Esophageal achalasia: is the herpes simplex virus really innocent?

Authors:  Ignazio Castagliuolo; Paola Brun; Mario Costantini; Christian Rizzetto; Giorgio Palù; Michela Costantino; Nicola Baldan; Giovanni Zaninotto
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

Review 6.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.